This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: University of California. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Roger S. Lo: Innovator in Melanoma Therapy
Introduction
Roger S. Lo is a prominent inventor based in Los Angeles, CA (US). He has made significant contributions to the field of oncology, particularly in the detection and treatment of metastatic melanomas. His innovative approaches aim to improve patient outcomes through personalized therapy.
Latest Patents
Roger S. Lo holds a patent for "Detection and treatment of anti-PD-1 therapy resistant metastatic melanomas." This patent outlines methods for predicting or detecting sensitivity to therapeutic effects of anti-PD-1 therapy in patients suffering from melanoma. The invention includes techniques such as whole transcriptome sequencing, antibody-based protein quantifications, and targeted sequencing to identify patients who are candidates for anti-PD-1 therapy. The method enhances the ability to select appropriate treatments based on individual tumor characteristics.
Career Highlights
Roger S. Lo is affiliated with the University of California, where he conducts research and develops innovative therapies. His work has garnered attention for its potential to transform the treatment landscape for melanoma patients. With 1 patent to his name, he continues to push the boundaries of cancer research.
Collaborations
Roger collaborates with esteemed colleagues, including Willy Hugo and Antoni Ribas. Their combined expertise contributes to advancing research in melanoma therapy and improving patient care.
Conclusion
Roger S. Lo is a key figure in the field of melanoma treatment, with a focus on personalized therapy through innovative methods. His contributions are paving the way for more effective cancer treatments and improving the lives of patients.